SOURCE: Brighton Markets

January 23, 2012 09:00 ET

2012 Economic Outlook - Report Highlights Merck & Co., Inc. and AstraZeneca plc (ADR)

HONG KONG--(Marketwire - Jan 23, 2012) - Today, www.BrightonMarkets.com announced new reports highlighting Merck & Co., Inc. (NYSE: MRK) and AstraZeneca plc (ADR) (NYSE: AZN). Gain market insight with full analysis and research downloads available at www.BrightonMarkets.com/index.php?coa=MRK&cob=AZN.

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Brighton Markets is releasing new coverage on Merck & Co., Inc. for its current position within the healthcare industry. Merck & Co., Inc. (Merck) is a global health care company. Merck delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates in four segments: Pharmaceutical, Animal Health, Consumer Care and Alliances. The full research report on Merck & Co., Inc. (NYSE: MRK) is available here: www.BrightonMarkets.com/index.php?coa=MRK.

Brighton Markets has released research on AstraZeneca plc (ADR) for its changing role within the healthcare industry. AstraZeneca plc (AstraZeneca) is a global biopharmaceutical company. AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. The full research report on AstraZeneca plc (ADR) (NYSE: AZN) is available here: www.BrightonMarkets.com/index.php?cob=AZN.

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.

Contact Information